Advanced search
Companies (1)
GeNeuro SA specializes in the development of safe and effective treatments against neurological disorders and autoimmune diseases such as multiple sclerosis or type 1 diabetes by neutralizing causal factors encoded by HERVs, which represent 8% of human DN ...
Capitalization | 63 M USD |
---|---|
Change | +2.63% |
1-year price change | +78.90% |
- Stock Market
- Advanced search
- Herv� Hoppenot
- Company Profiles